Prof. Heng Mei, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Prof. Jean-Marie Michot, Gustave Roussy, France
Prof. Mei and Prof. Michot discussed key strategies for managing relapse or refractoriness after CAR-T therapy, including the potential role of sequential CAR-T using the same or different targets. They also explored the challenges and prospects of combining or sequencing CAR-T with novel agents such as bispecific antibodies.